Literature DB >> 22405764

DACH1 regulates cell cycle progression of myeloid cells through the control of cyclin D, Cdk 4/6 and p21Cip1.

Jae-Woong Lee1, Hyeng-Soo Kim, Seonggon Kim, Junmo Hwang, Young Hun Kim, Ga Young Lim, Wern-Joo Sohn, Suk-Ran Yoon, Jae-Young Kim, Tae Sung Park, Kwon Moo Park, Zae Young Ryoo, Sanggyu Lee.   

Abstract

The cell-fate determination factor Dachshund, a component of the Retinal Determination Gene Network (RDGN), has a role in breast tumor proliferation through the repression of cyclin D1 and several key regulators of embryonic stem cell function, such as Nanog and Sox2. However, little is known about the role of DACH1 in a myeloid lineage as a cell cycle regulator. Here, we identified the differential expression levels of extensive cell cycle regulators controlled by DACH1 in myeloid progenitor cells. The forced expression of DACH1 induced p27(Kip1) and repressed p21(Cip1), which is a pivotal characteristic of the myeloid progenitor. Furthermore, DACH1 significantly increased the expression of cyclin D1, D3, F, and Cdk 1, 4, and 6 in myeloid progenitor cells. The knockdown of DACH1 blocked the cell cycle progression of HL-60 promyeloblastic cells through the decrease of cyclin D1, D3, F, and Cdk 1, 4, and 6 and increase in p21(Cip1), which in turn decreased the phosphorylation of the Rb protein. The expression of Sox2, Oct4, and Klf4 was significantly up-regulated by the forced expression of DACH1 in mouse myeloid progenitor cells.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22405764     DOI: 10.1016/j.bbrc.2012.02.120

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  BCOR Binding to MLL-AF9 Is Essential for Leukemia via Altered EYA1, SIX, and MYC Activity.

Authors:  Charles R Schmidt; Nicholas J Achille; Aravinda Kuntimaddi; Adam M Boulton; Benjamin I Leach; Shubin Zhang; Nancy J Zeleznik-Le; John H Bushweller
Journal:  Blood Cancer Discov       Date:  2020-09

2.  SIX1 and DACH1 influence the proliferation and apoptosis of hepatocellular carcinoma through regulating p53.

Authors:  Qi Cheng; Deng Ning; Jin Chen; Xue Li; Xiao-Ping Chen; Li Jiang
Journal:  Cancer Biol Ther       Date:  2018-02-12       Impact factor: 4.742

3.  Identification of transcriptional regulators in the mouse immune system.

Authors:  Vladimir Jojic; Tal Shay; Katelyn Sylvia; Or Zuk; Xin Sun; Joonsoo Kang; Aviv Regev; Daphne Koller; Adam J Best; Jamie Knell; Ananda Goldrath; Vladimir Joic; Daphne Koller; Tal Shay; Aviv Regev; Nadia Cohen; Patrick Brennan; Michael Brenner; Francis Kim; Tata Nageswara Rao; Amy Wagers; Tracy Heng; Jeffrey Ericson; Katherine Rothamel; Adriana Ortiz-Lopez; Diane Mathis; Christophe Benoist; Natalie A Bezman; Joseph C Sun; Gundula Min-Oo; Charlie C Kim; Lewis L Lanier; Jennifer Miller; Brian Brown; Miriam Merad; Emmanuel L Gautier; Claudia Jakubzick; Gwendalyn J Randolph; Paul Monach; David A Blair; Michael L Dustin; Susan A Shinton; Richard R Hardy; David Laidlaw; Jim Collins; Roi Gazit; Derrick J Rossi; Nidhi Malhotra; Katelyn Sylvia; Joonsoo Kang; Taras Kreslavsky; Anne Fletcher; Kutlu Elpek; Angelique Bellemarte-Pelletier; Deepali Malhotra; Shannon Turley
Journal:  Nat Immunol       Date:  2013-04-28       Impact factor: 25.606

4.  Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.

Authors:  Helit Cohen; Rotem Ben-Hamo; Moriah Gidoni; Ilana Yitzhaki; Renana Kozol; Alona Zilberberg; Sol Efroni
Journal:  Breast Cancer Res       Date:  2014-11-20       Impact factor: 6.466

5.  Decreased DACH1 expression in glomerulopathy is associated with disease progression and severity.

Authors:  Qing-Quan Liu; Ya-Qun Zhou; Hui-Quan Liu; Wen-Hui Qiu; Hui Liu; Ting-Yang Hu; Qing Xu; Yong-Man Lv; Kong-Ming Wu
Journal:  Oncotarget       Date:  2016-12-27

6.  DACH1 inhibits SNAI1-mediated epithelial-mesenchymal transition and represses breast carcinoma metastasis.

Authors:  F Zhao; M Wang; S Li; X Bai; H Bi; Y Liu; X Ao; Z Jia; H Wu
Journal:  Oncogenesis       Date:  2015-03-16       Impact factor: 7.485

7.  A comprehensive look at transcription factor gene expression changes in colorectal adenomas.

Authors:  Janine Vonlanthen; Michal J Okoniewski; Mirco Menigatti; Elisa Cattaneo; Daniela Pellegrini-Ochsner; Ritva Haider; Josef Jiricny; Teresa Staiano; Federico Buffoli; Giancarlo Marra
Journal:  BMC Cancer       Date:  2014-01-29       Impact factor: 4.430

8.  DACH1 inhibits the proliferation and invasion of lung adenocarcinoma through the downregulation of peroxiredoxin 3.

Authors:  Ji Zhu; Cong Wu; Huafei Li; Yang Yuan; Xiaotian Wang; Tiejun Zhao; Jibin Xu
Journal:  Tumour Biol       Date:  2016-01-25

9.  Galectin-3 inhibition ameliorates hypoxia-induced pulmonary artery hypertension.

Authors:  Mingwen Hao; Miaomiao Li; Wenjun Li
Journal:  Mol Med Rep       Date:  2016-12-09       Impact factor: 2.952

10.  Correlation between single nucleotide polymorphisms of DACH1 gene microRNA binding site and susceptibility of patients with endometrial cancer.

Authors:  Liyan Xu; Yafen Qiu; Ling Feng; Li Zhou; Xufeng Chen; Dongqi Yu
Journal:  Medicine (Baltimore)       Date:  2020-06-19       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.